MedPath

A clinical trial to evaluate the influence of Casein Phosphopeptide-Amorphous Calcium Phosphate (CPP-ACP) – Cranberry toothpastes in changing the bacterial composition of dental plaque deposits on teeth of orthodontic patients.

Not Applicable
Completed
Conditions
Dental caries
Oral and Gastrointestinal - Other diseases of the mouth, teeth, oesophagus, digestive system including liver and colon
Registration Number
ACTRN12618000095268
Lead Sponsor
Prof. Laurence Walsh
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
90
Inclusion Criteria

(1)Undergoing fixed orthodontic treatment in both arches, with treatment having been underway for at least 1 month, (2) A minimum of 10 years of age and at least 4 fully erupted permanent maxillary anterior teeth. (3) Good general physical health as determined by a review of the medical history, (4) Available to attend a review appointment in 4 weeks, and (5) Not currently using antibiotics or any antibacterial/anti-plaque mouth rinses.

Exclusion Criteria

(1) Any medical condition or disability preventing normal manual tooth brushing, (2) Allergy to milk casein proteins or intolerance to any of the components of the CPP-ACP toothpastes, (3) Unwillingness to use a fluoridated dentifrice, (4) Untreated periodontal disease, (5) Clinical evidence of active caries.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The study assessed whether the test toothpastes could effect a beneficial change in the bacterial load numbers of 14 key bacterial species (8 cariogenic and 6 health-associated bacterial species) in the dental plaque of trial participants over the 5-6 week trial period.<br><br>Molecular microbiological analysis of dental plaque samples will be done using real-time quantitative polymerase chain reaction (qPCR) by 16S rRNA sequencing of the relevant plaque bacteria. <br><br>It is hypothesized that using the test toothpastes will result in reduced bacterial loads of 'harmful' cariogenic bacteria and increased bacterial loads of 'healthy' commensal bacteria. [5-6 weeks after baseline appointment]
Secondary Outcome Measures
NameTimeMethod
one[Nil]
© Copyright 2025. All Rights Reserved by MedPath